Molecular modeling based approach, design synthesis and cytotoxic activity of 7-chloro-4-(2,5-dioxo-4-substitutedarylidine) piperazinoquinoline a hybrid pharmacophore, targeting EGFR, Tyrosine Kinase

Szakacs, 2006, Nat Rev Drug Discov, 5, 219, 10.1038/nrd1984 O’Connor, 2009, Curr Cancer Drug Targets, 9, 273, 10.2174/156800909788166583 Hu, 2008, Bioorg Med Chem, 16, 7888, 10.1016/j.bmc.2008.07.076 Hu C, Solomon VR, Cano P, Lee H. Eur J Med Chem, in press. doi:10.1016/j.ejmech.2009.11.017. Sella, 2009, Oncology, 76, 442, 10.1159/000217264 Keith, 2005, Nat Rev Drug Discov, 4, 71, 10.1038/nrd1609 Mayur, 2009, Curr Cancer Drug Targets, 9, 298, 10.2174/156800909788166619 Solomon, 2009, Bioorg Med Chem, 17, 7585, 10.1016/j.bmc.2009.08.068 Meunier, 2008, Acc Chem Res, 41, 69, 10.1021/ar7000843 Hubschwerlen, 2003, Bioorg Med Chem Lett, 13, 4229, 10.1016/j.bmcl.2003.07.028 Bhanot, 2001, Curr Pharm Des, 7, 311, 10.2174/1381612013398059 Adamec, 2007, Bioorg Med Chem, 15, 2898, 10.1016/j.bmc.2007.02.021 Kouznetsov, 2009, Eur J Med Chem, 44, 3091, 10.1016/j.ejmech.2009.02.024 Zhao, 2005, Radiat Res, 164, 250, 10.1667/RR3436.1 Atwell, 1988, J Med Chem, 31, 1048, 10.1021/jm00400a029 Atwell, 1989, J Med Chem, 32, 396, 10.1021/jm00122a018 Suzuki, 1997, J Med Chem, 40, 2047, 10.1021/jm960869l Wang, 1997, J Eur Haematol, 58, 186, 10.1111/j.1600-0609.1997.tb00946.x Zhang, 2008, Biomed Pharmacother, 62, 65, 10.1016/j.biopha.2007.04.007 Solomon, 2009, Eur J Pharmacol, 625, 220, 10.1016/j.ejphar.2009.06.063 Khaled, 2007, Bull Fac Pharm Cairo Univ, 45, 253 Solomon, 2010, Bioorg Med Chem, 18, 1563, 10.1016/j.bmc.2010.01.001 Sharma, 1998, Ultra Sci Phys Sci, 10, 263 Kuzamin, 2005, Environ Res, 16, 219 Skehan, 1990, Natl Cancer Inst, 82, 1107, 10.1093/jnci/82.13.1107 <http://www.rcsb.org/pdb/explore.do?StructureId=Ixkk>. Shewchuk, 2000, J Med Chem, 43, 133, 10.1021/jm990401t Edgar, 2004, Cancer Res, 64, 6652, 10.1158/0008-5472.CAN-04-1168 Assefa, 2003, J Comput Aided Mol Des, 17, 475, 10.1023/B:JCAM.0000004622.13865.4f